alendronate has been researched along with sodium pertechnetate tc 99m in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atherton, CT; Blackshaw, PE; Dansereau, RJ; Hay, PD; Lawes, SC; Perkins, AC; Schnell, DJ; Spiller, RC; Wagner, LK | 1 |
1 trial(s) available for alendronate and sodium pertechnetate tc 99m
Article | Year |
---|---|
Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Cross-Over Studies; Drugs, Generic; Esophagus; Etidronic Acid; Female; Gastrointestinal Transit; Humans; Middle Aged; Posture; Radionuclide Imaging; Radiopharmaceuticals; Risedronic Acid; Single-Blind Method; Sodium Pertechnetate Tc 99m; Tablets | 2008 |